Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

Melanoblasts as Multipotent Cells in Murine Skin.

Motohashi T, Kunisada T.

Methods Mol Biol. 2018 Jun 5. doi: 10.1007/7651_2018_144. [Epub ahead of print]

PMID:
30006864
2.

Direct Conversion of Mouse Embryonic Fibroblasts into Neural Crest Cells.

Motohashi T, Kunisada T.

Methods Mol Biol. 2018 May 24. doi: 10.1007/7651_2018_145. [Epub ahead of print]

PMID:
29797008
3.

Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma.

Yoshida A, Fujiwara T, Uotani K, Morita T, Kiyono M, Yokoo S, Hasei J, Nakata E, Kunisada T, Ozaki T.

Acta Med Okayama. 2018 Apr;72(2):165-174. doi: 10.18926/AMO/55857.

4.

Differential Organ-targeting and Cellular Characteristics of Metastatic Human Pancreatic Cancer Cell Lines in Mouse Models.

Satake T, Suetsugu A, Nakamura M, Hasegawa K, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2018 Apr;38(4):1927-1935.

PMID:
29599308
5.

Patients with osteosarcoma and soft tissue sarcoma might become "cancer refugees" in some Japanese regional cities.

Yamane H, Kunisada T, Ozaki T, Ochi N, Honda Y, Nagasaki Y, Nakagawa N, Yamagishi T, Nakanishi H, Takigawa N.

Cancer Manag Res. 2018 Feb 19;10:353-359. doi: 10.2147/CMAR.S155282. eCollection 2018.

6.

Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial Sarcoma.

Uotani K, Fujiwara T, Yoshida A, Iwata S, Morita T, Kiyono M, Yokoo S, Kunisada T, Takeda K, Hasei J, Numoto K, Nezu Y, Yonemoto T, Ishii T, Kawai A, Ochiya T, Ozaki T.

Sci Rep. 2017 Nov 7;7(1):14634. doi: 10.1038/s41598-017-12660-5.

7.

Priming with FGF2 stimulates human dental pulp cells to promote axonal regeneration and locomotor function recovery after spinal cord injury.

Nagashima K, Miwa T, Soumiya H, Ushiro D, Takeda-Kawaguchi T, Tamaoki N, Ishiguro S, Sato Y, Miyamoto K, Ohno T, Osawa M, Kunisada T, Shibata T, Tezuka KI, Furukawa S, Fukumitsu H.

Sci Rep. 2017 Oct 18;7(1):13500. doi: 10.1038/s41598-017-13373-5.

8.

Induced haploinsufficiency of Kit receptor tyrosine kinase impairs brain development.

Aoki H, Hara A, Kunisada T.

JCI Insight. 2017 Oct 5;2(19). pii: 94385. doi: 10.1172/jci.insight.94385. [Epub ahead of print]

9.

Galectin-1 enhances the generation of neural crest cells.

Motohashi T, Nishioka M, Kitagawa D, Kawamura N, Watanabe N, Wakaoka T, Kadoya T, Kunisada T.

Int J Dev Biol. 2017;61(6-7):407-413. doi: 10.1387/ijdb.160380tm.

PMID:
28695960
10.

Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction.

Yamakawa Y, Tazawa H, Hasei J, Osaki S, Omori T, Sugiu K, Komatsubara T, Uotani K, Fujiwara T, Yoshida A, Kunisada T, Urata Y, Kagawa S, Ozaki T, Fujiwara T.

Cancer Sci. 2017 Sep;108(9):1870-1880. doi: 10.1111/cas.13316. Epub 2017 Aug 3.

11.

Imaging the Role of Multinucleate Pancreatic Cancer Cells and Cancer-Associated Fibroblasts in Peritoneal Metastasis in Mouse Models.

Hasegawa K, Suetsugu A, Nakamura M, Matsumoto T, Aoki H, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2017 Jul;37(7):3435-3440.

PMID:
28668832
12.

Choline-Deficient-Diet-Induced Fatty Liver Is a Metastasis-Resistant Microenvironment.

Nakamura M, Suetsugu A, Hasegawa K, Matsumoto T, Aoki H, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2017 Jul;37(7):3429-3434.

PMID:
28668831
13.

Factors associated with the decision of operative procedure for proximal femoral bone metastasis: Questionnaire survey to institutions participating the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group.

Araki N, Chuman H, Matsunobu T, Tanaka K, Katagiri H, Kunisada T, Hiruma T, Hiraga H, Morioka H, Hatano H, Asanuma K, Nishida Y, Hiraoka K, Okamoto T, Abe S, Watanuki M, Morii T, Sugiura H, Yoshida Y, Ohno T, Outani H, Yokoyama K, Shimose S, Fukuda H, Iwamoto Y.

J Orthop Sci. 2017 Sep;22(5):938-945. doi: 10.1016/j.jos.2017.05.012. Epub 2017 Jun 17.

14.

Efficacy of Trabectedin in Patients with Advanced Translocation-Related Sarcomas: Pooled Analysis of Two Phase II Studies.

Takahashi M, Takahashi S, Araki N, Sugiura H, Ueda T, Yonemoto T, Morioka H, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Shimura M, Kawai A.

Oncologist. 2017 Aug;22(8):979-988. doi: 10.1634/theoncologist.2016-0064. Epub 2017 May 18.

PMID:
28526720
15.

Genetic Recombination Between Stromal and Cancer Cells Results in Highly Malignant Cells Identified by Color-Coded Imaging in a Mouse Lymphoma Model.

Nakamura M, Suetsugu A, Hasegawa K, Matsumoto T, Aoki H, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

J Cell Biochem. 2017 Dec;118(12):4216-4221. doi: 10.1002/jcb.26068. Epub 2017 Jun 9.

PMID:
28419513
16.

Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.

Fujiwara T, Uotani K, Yoshida A, Morita T, Nezu Y, Kobayashi E, Yoshida A, Uehara T, Omori T, Sugiu K, Komatsubara T, Takeda K, Kunisada T, Kawamura M, Kawai A, Ochiya T, Ozaki T.

Oncotarget. 2017 May 16;8(20):33375-33392. doi: 10.18632/oncotarget.16498.

17.

Acremopeptin, a new peptaibol from Acremonium sp. PF1450.

Iijima M, Amemiya M, Sawa R, Kubota Y, Kunisada T, Momose I, Kawada M, Shibasaki M.

J Antibiot (Tokyo). 2017 Jun;70(6):791-794. doi: 10.1038/ja.2017.15. Epub 2017 Feb 15. No abstract available.

PMID:
28196979
18.

A rare manifestation of extraskeletal myxoid chondrosarcoma with a huge expanding hematoma.

Omori T, Fujiwara T, Kunisada T, Takeda K, Hasei J, Yoshida A, Yanai H, Ozaki T.

J Orthop Sci. 2017 Feb 7. pii: S0949-2658(16)30272-X. doi: 10.1016/j.jos.2016.12.011. [Epub ahead of print] No abstract available.

PMID:
28187993
19.

Cellular context-dependent consequences of Apc mutations on gene regulation and cellular behavior.

Hashimoto K, Yamada Y, Semi K, Yagi M, Tanaka A, Itakura F, Aoki H, Kunisada T, Woltjen K, Haga H, Sakai Y, Yamamoto T, Yamada Y.

Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):758-763. doi: 10.1073/pnas.1614197114. Epub 2017 Jan 5.

20.

Neurological Recovery after Posterior Spinal Surgery in Patients with Metastatic Epidural Spinal Cord Compression.

Watanabe N, Sugimoto Y, Tanaka M, Mazaki T, Arataki S, Takigawa T, Kataoka M, Kunisada T, Ozaki T.

Acta Med Okayama. 2016 Dec;70(6):449-453.

21.

Disruption of Rest Leads to the Early Onset of Cataracts with the Aberrant Terminal Differentiation of Lens Fiber Cells.

Aoki H, Ogino H, Tomita H, Hara A, Kunisada T.

PLoS One. 2016 Sep 15;11(9):e0163042. doi: 10.1371/journal.pone.0163042. eCollection 2016.

22.

A Mouse Model of Fluorescent Protein-expressing Disseminated Peritoneal Lymphoma for Fluorescence-guided Surgery.

Matsumoto T, Suetsugu A, Hasegawa K, Nakamura M, Shibata Y, Aoki H, Kunisada T, Tsurumi H, Shimizu M, Bouvet M, Hoffman RM.

Anticancer Res. 2016 Sep;36(9):4483-7.

PMID:
27630285
23.

Color-coded Imaging Enables Fluorescence-guided Surgery to Resect the Tumor Along with the Tumor Microenvironment in a Syngeneic Mouse Model of EL-4 Lymphoma.

Hasegawa K, Suetsugu A, Nakamura M, Matsumoto T, Kunisada T, Shimizu M, Saji S, Moriwaki H, Bouvet M, Hoffman RM.

Anticancer Res. 2016 Sep;36(9):4443-8.

PMID:
27630280
24.

Color-coded Live Imaging of Heterokaryon Formation and Nuclear Fusion of Hybridizing Cancer Cells.

Suetsugu A, Matsumoto T, Hasegawa K, Nakamura M, Kunisada T, Shimizu M, Saji S, Moriwaki H, Bouvet M, Hoffman RM.

Anticancer Res. 2016 Aug;36(8):3827-31.

PMID:
27466484
25.

Pigmentation of regenerated hairs after wounding.

Yuriguchi M, Aoki H, Taguchi N, Kunisada T.

J Dermatol Sci. 2016 Oct;84(1):80-87. doi: 10.1016/j.jdermsci.2016.07.004. Epub 2016 Jul 6.

PMID:
27435302
26.

Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.

Morioka H, Takahashi S, Araki N, Sugiura H, Ueda T, Takahashi M, Yonemoto T, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Susa M, Nakayama R, Nishimoto K, Kikuta K, Horiuchi K, Kawai A.

BMC Cancer. 2016 Jul 14;16:479. doi: 10.1186/s12885-016-2511-y.

27.

Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas.

Osaki S, Tazawa H, Hasei J, Yamakawa Y, Omori T, Sugiu K, Komatsubara T, Fujiwara T, Sasaki T, Kunisada T, Yoshida A, Urata Y, Kagawa S, Ozaki T, Fujiwara T.

Sci Rep. 2016 Jun 30;6:28953. doi: 10.1038/srep28953.

28.

Imaging Nuclear-Cytoplasmic Dynamics in Primary and Metastatic Colon Cancer in Nude Mice.

Hasegawa K, Suetsugu A, Nakamura M, Matsumoto T, Aoki H, Kunisada T, Bouvet M, Shimizu M, Hoffman RM.

Anticancer Res. 2016 May;36(5):2113-7.

PMID:
27127111
29.

Color-Coded Imaging of Syngeneic Orthotopic Malignant Lymphoma Interacting with Host Stromal Cells During Metastasis.

Matsumoto T, Suetsugu A, Hasegawa K, Nakamura M, Aoki H, Kunisada T, Tsurumi H, Shimizu M, Hoffman RM.

Anticancer Res. 2016 Apr;36(4):1473-8.

PMID:
27069122
30.

Gene array analysis of neural crest cells identifies transcription factors necessary for direct conversion of embryonic fibroblasts into neural crest cells.

Motohashi T, Watanabe N, Nishioka M, Nakatake Y, Yulan P, Mochizuki H, Kawamura Y, Ko MS, Goshima N, Kunisada T.

Biol Open. 2016 Feb 12;5(3):311-22. doi: 10.1242/bio.015735.

31.

Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy.

Araki N, Takahashi S, Sugiura H, Ueda T, Yonemoto T, Takahashi M, Morioka H, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Kawai A.

Eur J Cancer. 2016 Mar;56:122-130. doi: 10.1016/j.ejca.2015.12.014. Epub 2016 Feb 2.

32.

Multipotency of melanoblasts isolated from murine skin depends on the Notch signal.

Watanabe N, Motohashi T, Nishioka M, Kawamura N, Hirobe T, Kunisada T.

Dev Dyn. 2016 Apr;245(4):460-71. doi: 10.1002/dvdy.24385. Epub 2016 Feb 17.

33.

microRNAs and Soft Tissue Sarcomas.

Fujiwara T, Kunisada T, Takeda K, Ozaki T.

Adv Exp Med Biol. 2015;889:179-99. doi: 10.1007/978-3-319-23730-5_10. Review.

PMID:
26659002
34.

Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin.

Abe Y, Okamura K, Kawaguchi M, Hozumi Y, Aoki H, Kunisada T, Ito S, Wakamatsu K, Matsunaga K, Suzuki T.

J Dermatol Sci. 2016 Jan;81(1):35-43. doi: 10.1016/j.jdermsci.2015.10.011. Epub 2015 Oct 27.

PMID:
26547111
35.

Erratum. Venous Thromboembolism after Total Hip Arthroplasty Diagnosed by Enhanced Computed Tomography:Comparison of Selective Thromboprophylaxis and No Thromboprophylaxis.

Okada Y, Endo H, Tanaka T, Mitani S, Fujiwara K, Tetsunaga T, Kagawa Y, Fujii Y, Kunisada T, Ozaki T.

Acta Med Okayama. 2015;69(5):325.

36.

Venous thromboembolism after total hip arthroplasty diagnosed by enhanced computed tomography:comparison of selective thromboprophylaxis and no thromboprophylaxis.

Okada Y, Endo H, Mitani S, Fujiwara K, Tetsunaga T, Kagawa Y, Fujii Y, Kunisada T, Ozaki T.

Acta Med Okayama. 2015;69(4):205-12. Erratum in: Acta Med Okayama. 2015;69(5):325.

37.

A Color-coded Imageable Syngeneic Mouse Model of Stromal-cell Recruitment by Metastatic Lymphoma.

Matsumoto T, Suetsugu A, Shibata Y, Nakamura N, Aoki H, Kunisada T, Tsurumi H, Shimizu M, Hoffman RM.

Anticancer Res. 2015 Sep;35(9):4647-54.

PMID:
26254354
38.

Immunotherapy for Bone and Soft Tissue Sarcomas.

Uehara T, Fujiwara T, Takeda K, Kunisada T, Ozaki T, Udono H.

Biomed Res Int. 2015;2015:820813. doi: 10.1155/2015/820813. Epub 2015 Jun 17. Review.

39.

Brefeldin A exerts differential effects on anaplastic lymphoma kinase positive anaplastic large cell lymphoma and classical Hodgkin lymphoma cell lines.

Toda T, Watanabe M, Kawato J, Kadin ME, Higashihara M, Kunisada T, Umezawa K, Horie R.

Br J Haematol. 2015 Sep;170(6):837-46. doi: 10.1111/bjh.13508. Epub 2015 Jun 24.

PMID:
26105086
40.

Diagnostic value of Thallium-201 scintigraphy in differentiating malignant bone tumors from benign bone lesions.

Inai R, Shinya T, Tada A, Sato S, Fujiwara T, Takeda K, Kunisada T, Yanai H, Ozaki T, Kanazawa S.

Ann Nucl Med. 2015 Oct;29(8):674-81. doi: 10.1007/s12149-015-0990-6. Epub 2015 Jun 3.

PMID:
26036991
41.

CORRIGENDUM: The Evidence of Glioblastoma Heterogeneity.

Soeda A, Hara A, Kunisada T, Yoshimura S, Iwama T, Park DM.

Sci Rep. 2015 May 26;5:9630. doi: 10.1038/srep09630. No abstract available.

42.

Hair follicle melanocyte precursors are awoken by ultraviolet radiation via a cell extrinsic mechanism.

Ferguson B, Kunisada T, Aoki H, Handoko HY, Walker GJ.

Photochem Photobiol Sci. 2015 Jun;14(6):1179-89. doi: 10.1039/c5pp00098j.

PMID:
25966309
43.

Both a visual and a semiquantitative analysis for differentiating benign from malignant chondrogenic bone tumors using Tc-99m (V) DMSA scintigraphy: a prospective study.

Shinya T, Sato S, Kunisada T, Inai R, Yanai H, Ozaki T, Kanazawa S.

Nucl Med Commun. 2015 Aug;36(8):802-7. doi: 10.1097/MNM.0000000000000328.

PMID:
25932541
44.

White spotting phenotype induced by targeted REST disruption during neural crest specification to a melanocyte cell lineage.

Aoki H, Hara A, Kunisada T.

Genes Cells. 2015 May;20(5):439-49. doi: 10.1111/gtc.12235. Epub 2015 Mar 27.

45.

Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study.

Kawai A, Araki N, Sugiura H, Ueda T, Yonemoto T, Takahashi M, Morioka H, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Tanase T, Hasegawa T, Takahashi S.

Lancet Oncol. 2015 Apr;16(4):406-16. doi: 10.1016/S1470-2045(15)70098-7. Epub 2015 Mar 18.

PMID:
25795406
46.

Conditional Deletion of Kit in Melanocytes: White Spotting Phenotype Is Cell Autonomous.

Aoki H, Tomita H, Hara A, Kunisada T.

J Invest Dermatol. 2015 Jul;135(7):1829-1838. doi: 10.1038/jid.2015.83. Epub 2015 Mar 3.

47.

Extended multipotency of neural crest cells and neural crest-derived cells.

Motohashi T, Kunisada T.

Curr Top Dev Biol. 2015;111:69-95. doi: 10.1016/bs.ctdb.2014.11.003. Epub 2015 Jan 20. Review.

PMID:
25662258
48.

The evidence of glioblastoma heterogeneity.

Soeda A, Hara A, Kunisada T, Yoshimura S, Iwama T, Park DM.

Sci Rep. 2015 Jan 27;5:7979. doi: 10.1038/srep07979. Erratum in: Sci Rep. 2015;5:9630.

49.

Quinofuracins A-E, produced by the fungus Staphylotrichum boninense PF1444, show p53-dependent growth suppression.

Tatsuda D, Momose I, Someno T, Sawa R, Kubota Y, Iijima M, Kunisada T, Watanabe T, Shibasaki M, Nomoto A.

J Nat Prod. 2015 Feb 27;78(2):188-95. doi: 10.1021/np500581m. Epub 2015 Jan 22.

PMID:
25611347
50.

Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.

Mizuno T, Suzuki N, Makino H, Furui T, Morii E, Aoki H, Kunisada T, Yano M, Kuji S, Hirashima Y, Arakawa A, Nishio S, Ushijima K, Ito K, Itani Y, Morishige K.

Gynecol Oncol. 2015 May;137(2):299-305. doi: 10.1016/j.ygyno.2014.12.005. Epub 2014 Dec 23.

PMID:
25541259

Supplemental Content

Loading ...
Support Center